EU Regulators May Check Redactions In CTIS Documents To Boost Trial Transparency

 
• By Vibha Sharma

A new EU guideline addresses numerous questions raised by study sponsors on processes for protecting commercial and personal data while using the Clinical Trials Information System.

A businessman in formal wear signing a contract. Padlock Hologram icons over the working desk.
Sponsors Can Use A Mix Of Redaction And Deferral Processes To Protect Commercial Data • Source: Shutterstock

More from Europe

More from Geography